Investing IdeasBrowse All StocksMarkets
Have your own idea? Try our Stock Screener
Header cover image

U.K. (FTSE) Healthcare Services Industry Analysis

UpdatedFeb 15, 2026
DataAggregated Company Financials
Companies11
  • 7D0.8%
  • 3M2.4%
  • 1Y10.4%
  • YTD9.2%

The Healthcare Services industry has been flat over the last week, but Integrated Diagnostics Holdings has lost 3.5%. As for the the longer term, the industry is up 10% over the past 12 months. Earnings are forecast to grow by 22% annually.

Industry Valuation and Performance

Has the U.K. Healthcare Services Industry valuation changed over the past few years?

DateMarket CapRevenueEarningsPEAbsolute PEPS
Sun, 15 Feb 2026UK£2.3bUK£2.4bUK£57.3m30.1x40.9x1x
Tue, 13 Jan 2026UK£2.3bUK£2.4bUK£52.4m29x43.8x0.9x
Thu, 11 Dec 2025UK£2.1bUK£2.4bUK£52.1m26.2x40.2x0.9x
Sat, 08 Nov 2025UK£2.3bUK£2.4bUK£52.2m31x43.8x0.9x
Mon, 06 Oct 2025UK£2.4bUK£2.4bUK£52.7m32.4x45.2x1x
Wed, 03 Sep 2025UK£5.0bUK£5.0bUK£140.7m31.5x35.3x1x
Fri, 01 Aug 2025UK£4.9bUK£5.0bUK£147.5m31.5x33.5x1x
Sun, 29 Jun 2025UK£2.2bUK£2.5bUK£57.0m13.9x38.3x0.9x
Tue, 27 May 2025UK£2.0bUK£2.5bUK£56.2m14.8x36.1x0.8x
Thu, 24 Apr 2025UK£1.8bUK£2.5bUK£55.4m14.3x33.1x0.7x
Sat, 22 Mar 2025UK£1.8bUK£2.4bUK£46.4m15.2x38.7x0.7x
Mon, 17 Feb 2025UK£2.1bUK£2.3bUK£55.7m17x37x0.9x
Wed, 15 Jan 2025UK£1.9bUK£2.3bUK£55.4m20.2x35.1x0.8x
Fri, 13 Dec 2024UK£2.0bUK£2.3bUK£55.7m19.3x35x0.8x
Sun, 10 Nov 2024UK£1.9bUK£2.3bUK£56.6m15.3x33.9x0.8x
Tue, 08 Oct 2024UK£2.2bUK£2.4bUK£55.2m27.1x39.1x0.9x
Thu, 05 Sep 2024UK£2.3bUK£2.2bUK£58.1m17.9x39.1x1x
Sat, 03 Aug 2024UK£2.2bUK£2.2bUK£56.5m16.8x39x1x
Mon, 01 Jul 2024UK£2.1bUK£2.3bUK£65.5m16.1x31.6x0.9x
Wed, 29 May 2024UK£2.2bUK£2.2bUK£60.3m19.6x36.2x1x
Fri, 26 Apr 2024UK£2.1bUK£2.2bUK£60.1m19.6x35.1x0.9x
Sun, 24 Mar 2024UK£2.1bUK£2.2bUK£59.3m20.5x35.6x0.9x
Tue, 20 Feb 2024UK£2.6bUK£2.2bUK£65.9m19.8x39.2x1.2x
Thu, 18 Jan 2024UK£7.6bUK£6.5bUK£312.7m21.9x24.4x1.2x
Sat, 16 Dec 2023UK£7.6bUK£6.5bUK£312.6m21.9x24.4x1.2x
Mon, 13 Nov 2023UK£7.5bUK£6.5bUK£308.8m19.2x24.2x1.2x
Wed, 11 Oct 2023UK£7.6bUK£6.5bUK£308.8m22.6x24.5x1.2x
Fri, 08 Sep 2023UK£7.7bUK£6.4bUK£283.8m22x27.1x1.2x
Sun, 06 Aug 2023UK£8.1bUK£6.4bUK£285.5m25.8x28.2x1.3x
Tue, 04 Jul 2023UK£7.8bUK£6.4bUK£285.1m36.1x27.5x1.2x
Thu, 01 Jun 2023UK£8.0bUK£6.4bUK£289.0m36x27.5x1.2x
Sat, 29 Apr 2023UK£8.0bUK£6.4bUK£288.8m36.3x27.7x1.2x
Mon, 27 Mar 2023UK£7.6bUK£6.4bUK£295.6m25.3x25.8x1.2x
Wed, 22 Feb 2023UK£7.9bUK£6.4bUK£292.1m26.9x26.9x1.2x
Price to Earnings Ratio

26.9x


Total Market Cap: UK£7.9bTotal Earnings: UK£292.1mTotal Revenue: UK£6.4bTotal Market Cap vs Earnings and Revenue0%0%0%
U.K. Healthcare Services Industry Price to Earnings3Y Average 34x202420252026
Current Industry PE
  • Investors are optimistic on the British Healthcare industry, and appear confident in long term growth rates.
  • The industry is trading at a PE ratio of 40.9x which is higher than its 3-year average PE of 34.0x.
  • The industry is trading close to its 3-year average PS ratio of 1.0x.
Past Earnings Growth
  • The earnings for companies in the Healthcare industry have declined 42% per year over the last three years,
  • Revenues have also declined 27% per year.
  • This means overall sales from these companies are declining and profits are subsequently falling as well.

Industry Trends

Which industries have driven the changes within the U.K. Healthcare industry?

GB Market0.93%
Healthcare4.28%
Healthcare Services0.82%
Healthcare Facilities1.81%
Healthcare Distributors0%0
Healthcare Services-3.04%
Industry PE
  • Investors are most optimistic about the Healthcare Facilities industry which is trading above its 3-year average PE ratio of 31.8x.
    • Analysts are expecting annual earnings growth of 22.5%, which is higher than its past year's earnings decline of 28.7% per year.
  • Investors are most pessimistic about the Healthcare Services industry, which is trading below its 3-year average of 219x.
Forecasted Growth
  • Analysts are most optimistic on the Healthcare Facilities industry, expecting annual earnings growth of 22% over the next 5 years.
  • This is better than its past earnings decline of 29% per year.
  • In contrast, the Healthcare Services industry is expected to see its earnings grow by 18% per year over the next few years.

Top Stock Gainers and Losers

Which companies have driven the market over the last 7 days?

CompanyLast Price7D1YValuation
CVSG CVS GroupUK£13.962.9%
+UK£28.1m		31.7%PE51.8x
GENI GENinCodeUK£0.011-6.5%
UK£4.6m		-70.9%PS2.8x
SPI Spire Healthcare GroupUK£2.050.5%
+UK£4.0m		-10.7%PE44.6x
OHGR One Health GroupUK£2.304.1%
+UK£1.2m		9.5%n/a
TRLS Trellus HealthUK£0.00550%
UK£30.5k		-73.2%PS3.9x

Latest News

TRLS
UK£0.0055
Trellus Health
7D
0%
1Y
-73.2%
MPAL
UK£0.052
MedPal AI
7D
-2.3%
1Y
n/a
SPI
UK£2.05
Spire Healthcare Group
7D
0.5%
1Y
-10.7%

SPI: Stable Fair Value And Slight P/E Shift Will Support Upside

Analysts have marginally lifted their price target on Spire Healthcare Group, reflecting small tweaks to the discount rate and long term P/E assumptions rather than any major shift in the underlying £ fair value framework. Valuation Changes Fair Value: £2.65 per share is unchanged, with no revision to the core £ fair value estimate.
OHGR
UK£2.30
One Health Group
7D
4.1%
1Y
9.5%
IDHC
US$0.61
Integrated Diagnostics Holdings
7D
-3.5%
1Y
66.2%

IDHC: Higher Margins And Lower Future P/E Will Support Upside Potential

Analysts have adjusted their price target for Integrated Diagnostics Holdings slightly lower, citing a modestly higher discount rate, a reduced revenue growth assumption of 17.27%, and a lower future P/E of 11.07x, partly offset by a small uplift in the expected profit margin to 20.37%. Valuation Changes Fair Value Estimate: Unchanged at 0.80175, indicating no revision to the overall valuation output from the model inputs provided.
CVSG
UK£13.96
CVS Group
7D
2.9%
1Y
31.7%

CVSG: Completed Buyback And Steady Assumptions Will Support Balanced Near Term Returns

Analysts have nudged their price target on CVS Group slightly higher to reflect small updates to revenue growth and margin assumptions, while keeping fair value broadly unchanged in cash terms. What's in the News CVS Group completed a share buyback tranche covering 1,584,690 shares, representing 2.21% of the company, for a total of £20 million, under the programme announced on October 24, 2025 (Key Developments).
KOO
UK£1.24
Kooth
7D
-7.1%
1Y
-23.7%
GENI
UK£0.011
GENinCode
7D
-6.5%
1Y
-70.9%
EDX
UK£0.13
EDX Medical Group
7D
-1.9%
1Y
36.8%